Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 15.30
-0.20 (-1.29%)
Mar 4, 2026, 4:27 PM GMT
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 21.4 million as of March 4, 2026. Its market cap has decreased by -2.11% in one year.
Market Cap
21.40M
Enterprise Value
17.85M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
15.30
Market Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 21.40M, an increase of 146.16%. That is a compound annual growth rate of 4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 21.40M | 3.33% |
| Dec 31, 2025 | 20.71M | -32.34% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 61.94M |
| hVIVO | 54.57M |
| Ondine Biomedical | 53.25M |
| ImmuPharma | 38.91M |
| Poolbeg Pharma | 31.73M |
| Arecor Therapeutics | 27.37M |
| SkinBioTherapeutics | 24.15M |
| Aptamer Group | 23.60M |